 Hyperaldosteronism
"Hyperaldosteronism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
| Descriptor ID |
D006929
|
| MeSH Number(s) |
C19.053.800.604
|
| Concept/Terms |
Conn Syndrome- Conn Syndrome
- Syndrome, Conn
- Primary Hyperaldosteronism
- Hyperaldosteronism, Primary
- Conn's Syndrome
- Conns Syndrome
- Syndrome, Conn's
|
Below are MeSH descriptors whose meaning is more general than "Hyperaldosteronism".
Below are MeSH descriptors whose meaning is more specific than "Hyperaldosteronism".
This graph shows the total number of publications written about "Hyperaldosteronism" by people in this website by year, and whether "Hyperaldosteronism" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 | | 2023 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperaldosteronism" by people in Profiles.
-
Liu L, Casadaban L, Jensen A, Ho B, Neves da Silva H, Selph C, Hughes M, Trivedi P. To Use or Not to Use? Quantifying the Benefit of Microcatheter Use in Adrenal Vein Sampling. J Vasc Interv Radiol. 2023 12; 34(12):2203-2207.
-
Rizzolo K, Beck NM, Ambruso SL. Syndromes of Pseudo-Hyperaldosteronism. Clin J Am Soc Nephrol. 2022 04; 17(4):581-584.
-
Edelman ER, Butala NM, Avery LL, Lundquist AL, Dighe AS. Case 30-2020: A 54-Year-Old Man with Sudden Cardiac Arrest. N Engl J Med. 2020 Sep 24; 383(13):1263-1275.
-
Lana A, Alexander K, Castagna A, D'Alessandro A, Morandini F, Pizzolo F, Zorzi F, Mulatero P, Zolla L, Olivieri O. Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations. Proteomics Clin Appl. 2019 07; 13(4):e1800049.
-
Olivieri O, Cecconi D, Castagna A, Chiecchi L, Guarini P, Gunasekaran M, Morandini F, Brazzarola P, Zolla L, D'Alessandro A, Veglio F, Mulatero P, Pizzolo F. Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma. Mol Biosyst. 2014 Jun; 10(6):1281-9.
-
Mascolo M, Chu ES, Mehler PS. Abuse and clinical value of diuretics in eating disorders therapeutic applications. Int J Eat Disord. 2011 Apr; 44(3):200-2.
-
Glueck CJ, Morrison JA, Daniels S, Wang P, Stroop D. Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years. J Pediatr. 2011 Aug; 159(2):308-13.e2.
-
Cottrell DA, Bello FA, Falko JM. 17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism. Am J Med Sci. 1990 Dec; 300(6):380-2.
-
Mace JW, Hambidge KM, Gotlin RW, Dubois RS, Solomons CS, Katz FH. Magnesium supplementation in Bartter's syndrome. Arch Dis Child. 1973 Jun; 48(6):485-7.
-
Mace J, Hambidge KM, Gotlin R, Dubois R. Bartter's syndrome in blacks. N Engl J Med. 1971 Dec 23; 285(26):1488.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|